RLUEX Performance — Lazard US Equity Concentrated Portfolio, R6 Shares

Data updated: 2026-05-28

RLUEX returned −4.03% year to date and +19.01% over one year to Mar 2026. Annualised returns are +7.52% over 3 years and +4.70% over 5 years. Against its US Large Value category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $124, against $150 for the category, and to $119 over one year, against $115. Volatility over the past three years was 16.67% a year. In the 12 months to Mar 2026 the fund lost a net $23.6M, and assets reached $31.69M.

RLUEX Growth of $100

What $100 invested in Lazard US Equity Concentrated Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Value category average over the same months.

PeriodRLUEXCategory average
1 year (Apr 2025 – Mar 2026)$119$115
3 years (Apr 2023 – Mar 2026)$124$150
5 years (Apr 2021 – Mar 2026)$126$159
Since data start (Jul 2019 – Mar 2026)$162$203

RLUEX Trailing Returns

Total returns to Mar 2026, from SEC N-PORT.

PeriodTotal return
YTD−4.03%
1 year+19.01%
3 years (annualised)+7.52%
5 years (annualised)+4.70%

RLUEX Annual Returns

Calendar-year total returns of Lazard US Equity Concentrated Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2026 (Jan–Mar)−4.03%
2025+7.70%
2024+12.46%
2023+16.75%
2022−19.87%
2021+26.07%
2020+8.89%
2019 (Jul–Dec)+8.33%

RLUEX Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2026+4.5%−4.3%−4.0%—————————
2025+7.7%−7.3%−13.0%−2.2%+4.6%+7.5%+4.0%−2.0%+1.9%+4.7%+3.0%+0.7%
2024−1.7%+2.4%+2.9%−4.6%+1.9%+4.0%+2.1%+6.1%+1.7%−0.4%+2.6%−4.5%
2023+8.5%−3.3%+4.1%+0.2%−1.5%+6.3%+0.3%−3.7%−5.0%−4.2%+9.9%+5.5%
2022−5.9%−2.9%+3.0%−5.3%−1.6%−7.7%+9.4%−6.0%−9.5%+5.8%+5.4%−4.7%
2021−1.6%+5.6%+4.8%+6.4%−1.2%+1.2%+2.6%+1.9%−4.1%+4.9%−2.1%+5.7%
2020+1.8%−8.9%−14.2%+11.0%+5.2%−0.4%+3.1%+5.0%−1.4%−1.8%+9.9%+2.1%
2019——————+3.4%−1.0%+0.9%−0.4%+1.9%+3.3%

RLUEX Risk

Risk measures from monthly returns over Apr 2023 – Mar 2026.

  • 3-year volatility (annualised): 16.67%
  • 3-year Sharpe ratio: 0.18 (vs 4.5% risk-free rate)
  • Best month: +9.93% (Nov 2023)
  • Worst month: −12.95% (Mar 2025)

RLUEX Fund Flows

Monthly money in and out of Lazard US Equity Concentrated Portfolio, from SEC Form N-PORT.

  • 12-month net flow: −$23.6M
  • 12-month gross sales (incl. reinvestments): $1.4M
  • Sales ÷ redemptions: 0.06×
MonthSalesRedemptionsNet flow
Mar 2026$27K$1.3M−$1.3M
Feb 2026$13K$1.4M−$1.4M
Jan 2026$728K$753K−$25K
Dec 2025$43K$3.3M−$3.2M
Nov 2025$37K$2.4M−$2.4M
Oct 2025$68K$2.2M−$2.1M
Sep 2025$108K$1.0M−$925K
Aug 2025$114K$749K−$635K
Jul 2025$53K$1.0M−$994K
Jun 2025$29K$2.5M−$2.4M
May 2025$50K$6.4M−$6.3M
Apr 2025$163K$2.0M−$1.8M

RLUEX Assets Under Management

Net assets of Lazard US Equity Concentrated Portfolio by report date, from SEC N-PORT filings.

Report dateNet assets
2026-03-31$31.69M
2025-12-31$35.74M
2025-09-30$40.20M
2025-06-30$41.25M
2025-03-31$47.38M
2024-12-31$61.90M
2024-09-30$84.31M
2024-06-30$95.04M
2024-03-31$142.89M
2023-12-31$204.56M
2023-09-30$345.49M
2023-06-30$596.06M

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.